SynthesisClinical rheumatology2015
Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis.
Markus Bredemeier et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it